We have recently shown that isoproterenol, a a-adrenergic stimulant, enhanced the cytotoxic effect of mitomycin C (MMC) on HeLa cells and some rat ascites hepatoma (AH) cells (1, 2) . Furthermore, it has been suggested that cyclic adenosine 3':5' monophosphate (cyclic AMP) in AH44 and AH130 cells elevated by this drug increased the uptake of MMC (3). The present paper deals with the effects of several sympathomi metic drugs on the cytotoxicity and the uptake of MMC in AH130 cells.
Agents obtained from commercial sources were mitomycin C (MMC, Sankyo Co.); I isoproterenol hydrochloride, I-epinephrine bitartrate, I-norepinephrine hydrochloride, and dl-propranolol hydrochloride (Sigma Chemi cals Co.); and dl-phentolamine mesylate (Ciba-Geigy Japan Ltd.). dl-Salbutamol hemisulfate and dl-tulobuterol hydrochloride were kindly provided by Hokuriku Seiyaku Co., Katsuyama.
Rat ascites hepatoma AH1 30 cells were maintained serially by the intraperitoneal passage at weekly intervals in female Donryu rats (weight 100-150 g, Shizuoka Laboratory Animal Center). The cells were withdrawn from the abdominal cavity of a rat at 7 to 9 days after the their implantation, washed with Hanks' solution to remove red blood cells (4); and the amounts of MMC taken up into the cells were determined from the decreased amount of MMC in the supernatant as described elsewhere (3) . Figure 1 shows the effects of sympa thomimetic drugs on the cytotoxic effect and the uptake of MMC. Isoproterenol, epine phrine and norepinephrine significantly potentiated the cytotoxicity of MMC, and 1 x 10-7 M of each drug was the most effective dose. However, salbutamol and tulobuterol, which were reported to act as 132-agonists (5), and phenylephrine, an a agonist, hardly influenced the cytotoxic effect of MMC (Fig. 1A) . The dose-response curve of MMC was shifted to the left by the pretreatment with isoproterenol, epinephrine or norepinephrine (data not shown). The effects of these drugs on the uptake of MMC are shown in Fig. 1 B. The cells treated with isoproterenol, epinephrine or norepinephrine took up MMC about twice as much as non treated cells. However, salbutamol, tulobu terol and phenylephrine did not change the uptake of MMC. Thus, it was confirmed that the enhancement of the cytotoxic effect of MMC was related to the increase of the uptake of MMC by (3-adrenergic agonists, except for 132-agonists. It is known that rat liver cells contain only i32-receptor among the subtypes of 13-adrenoceptor (6) . On the other hand, we have suggested that rat ascites hepatoma cells may possess some receptors having similar properties to the mammalian j31 -receptor because their adenylate cyclase hardly responded to / 2 agonists, and the enzyme activity stimulated by isoproterenol was more selectively inhibited by 81-antagonists in hepatoma cells than in normal rat liver cells (7) . This study also indicates that 132-agonists are not potent for enhancing the cytotoxic effect of MMC and not potent for increasing the uptake of MMC. Our recent papers (1, 2) have indicated that isoproterenol elevated intracellular cyclic AMP via (9-adrenoceptors, and MMC prolonged the term of the high cyclic AMP level, suggesting that the intracellular cyclic AMP elevated by the combined action of isoproterenol and MMC enhanced the uptake and the antitumor effect of MMC. The enhancement of MMC uptake by isopro terenol or norepinephrine was diminished by the (3-antagonist propranolol, but not diminished by the a-antagonist phentolamine (Fig. 2) . Phenylephrine which acts through a-adrenoceptors was not effective on the cytotoxicity and the uptake of MMC (Fig. 1 ) . Consequently, this study indicates that the enhanced cytotoxicity of MMC is obtained 
